NASDAQ: XGN
Exagen Inc Earnings Dates, Reports, Calls

Exagen earnings were -$16.9M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest XGN earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$5.0M, up 69.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, XGN reported annual earnings of -$23.7M, with -50% growth.

XGN earnings history

Current Revenue
$55.8M
Current Earnings
-$16.9M
Current Profit Margin
-30.4%

XGN Return on Equity

Current Company
-92.6%
Current Industry
-15.5%
Current Market
36.1%
XGN's Return on Equity (-92.6%)... subscribe to Premium to read more.
High Return on Equity Performance

XGN Return on Assets

Current Company
-33.7%
Current Industry
5.7%
XGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when XGN announces earnings.

XGN Return on Capital Employed

Current Company
-42.08%
Current Industry
10.3%
XGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XGN vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
XGN-$11.96M-$16.93MN/A-$0.94
VNRX-$28.22M-$29.87MN/A-$0.36
BNRN/A-$79.49MN/A-$7.76
ENZ-$24.61M-$26.08MN/A-$0.51
PREN/A-$49.01MN/A-$3.99

Exagen Earnings Reports & History FAQ

What were Exagen's earnings last quarter?

On XGN's earnings call on Invalid Date, Exagen (NASDAQ: XGN) reported Q3 2024 earnings per share (EPS) of -$0.28, up 9.68% year over year. Total XGN earnings for the quarter were -$5.03 million. In the same quarter last year, Exagen's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Exagen stock.

Is Exagen profitable or losing money?

As of the last Exagen earnings report, Exagen is currently losing money. Exagen's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$16.93 million, a 47.87% decrease year over year.

What was XGN's earnings growth in the past year?

As of Exagen's earnings date in Invalid Date, Exagen's earnings has grown year over year. XGN earnings in the past year totalled -$16.93 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.